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 Abstract: Graphene which has only recently been identified has 
drawn attention of many scientists due to its exclusive properties 
particularly the platelet-like shape which it exhibits .This shape 
seems to be pivotal to its toxicity potential.[8] This fairly novel 
material can cause unusual risks to the health of workers following 
pulmonary exposure in the occupational environment. This study 
combines literature review of the toxicity potential of graphene 
materials with different characterizations following pulmonary 
exposure. The studies use two different exposure techniques 
namely instillation and inhalation, therefore a comparison was 
made to see which of the two was a more effective method. 
Moreover, experimental data from an ongoing study assessing 
short and long term inflammation and total protein concentration 
in BAL fluid of Graphene oxide (GO) and reduced graphene 
oxide(rGO) was included and compared to the results from the 
literature studies. The results obtained from our study showed 
that from exposure to rGO there occurred increased inflammation 
1 day post exposure, compared to VC and Carbon Black (CB). The 
inflammation decreased afterwards up to 3 months Whereas, 
from exposure to GO, there was an increase in inflammation, until 
Day 2,which then decreased until after 3 months. Further, the 
results showed that GPs which went up to 25μm in diameter 
caused inflammation and frustrated phagocytosis. [8, 10] 
Currently, only a few literary studies using inhalation as the 
exposure technique exist. This technique simulates real life 
exposure therefore more research needs to be conducted in 
future to further investigate the medium term and long term 
effects of exposure to graphene materials. 
Pulmonary 
exposure to 
graphene 
materials in 
the working 
enviornment 
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Glossary 
 
ALP - Alkaline phosphatase activity 
BCA - Bicinchoninic acid 
BAL - Bronchoalveolar lavage 
BSA - Bovine serum albumin 
CB - Carbon black 
CNT - Carbon nanotubes 
GP - Graphene nanoplatelet(s) 
LDH - Lactate dehydrogenase activity  
NP - Nanoparticle(s) 
GO - Graphene oxide 
rGO - reduced Graphene oxide 
PK - pharmacokinetics 
RES - Reticuloendothelial system 
ROS - Reactive oxygen species 
VC - Vehicle control 
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  Chapter 1: Introduction and Theoretical Framework 
Introduction 
Since the beginning of the industrial revolution humans have been exposed to nanoparticles 
(NPs; <100nm), and this exposure has increased dramatically with the rapidly developing field 
of nanotechnology. [16] NPs are developed to display some novel characteristics such as 
increased chemical reactivity or conductivity of the materials as compared to the materials at 
larger sizes[1].In addition to being widely used already in a lot of our day to day products, for 
example, in batteries and anti-bacterial clothing coatings, the use of nano innovation is fast 
spreading into many other sectors including security and space, transport, energy, innovation, 
environment, public health, employment and occupational safety and health ,information 
society, industry. The analysts expect the market of NPs to grow to hundreds of billions of Euros 
by the end of 2015.[1] Recently, for example, carbon nanotubes(CNTs) have been used in 
spacecrafts [17] and the newly discovered nanomaterial, graphene nanoplatelets (GPs), have 
also shown properties that fulfil the dynamic aerospace requirements [17]. These unique 
properties of GPs have further enabled applications in biomedicine,for example, for the design 
and delivery of vehicles for diagnostics, ultrasensitive sensors, biomarkers and  tissue 
engineering. [17] Another fairly new and interesting application of GPs is DNA sequencing[21]. 
In 2010, three independent research groups reported manufacturing double-stranded DNA 
molecules through nanopores in suspended graphene membranes [18, 19, 20].  
Although NPs can be used in different applications, they may pose a risk to the environment as 
well as to the health of the people exposed to them. Unintentional occupational or 
environmental exposure to GPs and related materials during manufacturing or intentional 
exposure via biomedical applications is likely to increase with their advancement and use in 
various applications [8]. 
These NPs have many different effects and on different organs of the body due to translocation 
of the particles. Deposition of NPs such as GPs, CNTs and Titanium oxide(TiO2) in the lungs, 
which is the primary target due to the pulmonary exposure in the working environment, can 
lead to pulmonary inflammation [4, 8, 16].Inflammation is defined as the response of 
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vascularized tissues to cell injury or death [28]. This lung exposure can prove to be detrimental 
to one’s health since they are deposited deep in the alveolar regions during inhalation leading 
to potentially fatal pulmonary diseases.  
A striking feature of many NPs including CNTs and metal oxides is their ability in some cases to 
induce genotoxicity and increase the risk of cancer [4, 16]. GPs which have also followed the 
description, isolation and mass fabrication of CNTs and fullerenes [33] could also be causing the 
similar risks in humans. Moreover, since the development and industrial applications of GPs has 
increased and tends to increase further [30, 33] there is a need to determine the safety profile 
of GPs. However currently, very little is known about the negative impact the newly discovered 
GPs have on exposed objects. This lack of knowledge is posing the biggest challenge to the 
researchers therefore more mechanistic and systematic studies exploring the toxicity of NPs is 
crucially needed. 
Hence, the aim of this report is to make a review on toxicity of the fairly novel GPs following 
pulmonary exposure, using in vivo studies. This review is made based on a combination of the 
currently existing literature describing the toxicology of different derivatives of graphene , our 
own experimental data regarding both long and short term protein measurements and 
unpublished data on inflammation received from our Supervisor. Work in this paper will also 
make comparisons between the toxicity of GPs and currently existing knowledge we have on 
related carbon-based NPs such as CNTs.  
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Chapter 2: Background 
Nanotoxicology 
Nanoscience has been a focus of many researchers in the last decade and has gained a lot of 
ground since it has graduated to applied technology from a once trivial science. Currently, NPs 
are used in an extensive variety of commercial products such as electronic components, sports 
equipment, and biomedical applications. [3] 
Carbon-based NPs that have been widely explored include fullerenes and CNTs.[17] Figure 1 
shows  how these widely explored NPs compare with the newly discovered GPs and other 2D 
heterostructures in terms of their structure and properties. 
 
 
Figure 1: Different forms of NPs and their unique properties used in biomedical application. Modified from [17] 
 
Few studies have been conducted on the long-term effects of NP exposure on the human 
health but questions have been raised on the effects of different NPs, and if they all have the 
same affects as each other.  
It has long been established that carcinogens such as asbestos have really detrimental long-
term effects on the human health in particular the lungs. For example, exposure to asbestos 
fibres in poorly regulated workplaces caused a worldwide epidemic of a range of lung and 
pleural diseases such as lung fibrosis, lung cancer, pleural plaques, pleural effusion and pleural 
mesothelioma. [8, 22, 25] However, the exact mechanism through which the long fiber shaped 
materials demonstrate their harmful effects is only partially understood so far but this 
mechanism involves a variety of events such as retention of long fibres in the lung due to failed 
clearance by alveolar macrophages leading to frustrated phagocytosis and the trading of 
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neutrophils to the site of fiber retention. After translocation to the pleura, the long fibres are 
reserved at the stomata at the parietal pleura inducing inflammation and extended pleural 
interaction between the fibres and the mesothelial cells. [8, 23, 24, 25] 
What is now being questioned is whether or not other seemingly harmless materials such as 
CNTs which are also fiber-shaped just as asbestos, and GPs which are have a platelet like 
structure should be treated with the same caution afforded to the harmful ones such as the 
carcinogens. [3, 25, 29] 
 
Graphene 
Graphene is a fairly novel nanomaterial. (Figure 1)Graphene materials comprise of pristine 
graphene sheets, few-layer graphene flakes, graphene oxide (GO) and many others. These 
graphene materials have a range of unique and versatile properties that have many 
applications for example in biomedicine [17]. It is the thinnest and most robust 2 dimensional 
atom ever known to exist. It is made up of a single layer of tightly packed carbon atoms with a 
platelet-like shaped structure (Figure 1).Because of its thin, transparent 2D structure; it is really 
hard to break down GPs. It can hold very large quantities of weight despite being really thin and 
light in weight as it is 100-300 times stronger than steel. [17, 30] 
The global growth of GPs particularly aimed at industrial applications has increased significantly 
in the recent years. [30] Graphene sheets are being produced in hundreds of tonnes and tens of 
thousands of square meters particularly in China where the total production capacity of small 
graphene sheets and graphene films exceeds 400 tonnes and 110,000 m2. [30]  
 
Exposure techniques in vivo studies 
The major route of exposure for the NPs in the working environment is pulmonary exposure. 
Most pre-existing in vivo studies use inhalation and intratracheal instillation in mice as exposure 
methods. A thorough understanding of the differences between instillation and inhalation 
methods is necessary to avoid misinterpretation of instillation-derived results. The main 
difference between the two exposure methods is the dose rate, i.e a few seconds with 
intratracheal instillation and a longer time (minutes, hours, days, weeks or even months) with 
inhalation.  
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Inhalation 
Inhalation serves as the natural route of entry for most airborne particles; therefore this 
method takes a much more realistic approach in the measure of the toxic effects of GPs on the 
human pulmonary system. For that reason, it is the preferred method of exposure of toxicants 
into the lungs.  
A typical inhalation experiment would involve rats/mice being kept in controlled environments 
exposed to NPs and inhaling it daily over a given amount of time and then the results are 
recorded. However, designing and building an inhalation exposure system that is both practical 
and effective, matching the appropriate generation and characterisation of exposure 
environments involves special equipment and expertise which is expensive to get and maintain 
[7]. 
This method also comes with some disadvantages for instance, the test material may be so 
highly toxic to the point that safety issues such as dermal/fur contamination may occur. 
Another disadvantage can occur in the form of the test material being too limited for 
generation of atmospheres at sufficient concentrations for an adequate duration so as to allow 
testing by inhalation. [7] 
 
Instillation (Bollus exposure) 
This method typically employs intratracheal instillation or pharyngeal aspiration techniques in 
animal models. Because of the limited exposure techniques, the results obtained are also 
limited with regard to reflecting the real exposure (inhalation) situation in an occupational or 
environmental setting.  This means that the exposure of animals to the GPs can possibly 
produce different toxic responses hence not providing a completely realistic view into the level 
of toxicity as compared to inhalation. [5]  
This method is however a very useful and cost-effective procedure. The actual dosage delivered 
to the lungs of each animal can essentially be assured.[7] For the laboratory workers,this 
method is also a lot more simple and safer to conduct as compared to inhalation exposure 
methods because it reduces exposure to potentially toxic, carcinogenic or radioactive materials. 
Another advantage is that it permits the introduction of a range of doses to the lungs within a 
short period and hence avoids exposure to the fur. 
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Inflammation  
Inflammation is a biological, protective immune response of body tissues to injury or tissue 
damage.[34,35] Inflammation is characterised by vasodilation, increased blood flow, cellular 
influx, release of soluble mediators and elevated cellular metabolism among other symptoms. 
Under normal conditions, the inflammatory process is self-limiting and occurs almost as a reflex 
action to injury; however, sometimes the process becomes continuous leading to chronic 
inflammatory diseases. [34] 
Depending on the immune system’s response, the inflammatory process may either be acute or 
chronic. Infiltration/disturbance of innate system cells such as neutrophils and macrophages 
will often result in acute inflammation whereas infiltration of T lymphocytes and plasma cells 
will result in chronic inflammation. Chronic inflammation has more long term and far more 
devastating results on the disturbed body organ than acute inflammation which is more short-
term. One of the end results of chronic inflammation is the total loss of tissue function due to 
fibrosis.[34] Once this stage i.e. chronic inflammation has been reached, very little can be done.  
The key role of acute inflammation is to eliminate the agents which cause injury and to limit the 
tissue damage [28]. The innate system cells which upon disturbance cause acute inflammation, 
serve as pathogen recognition receptors. They are also responsible for identifying and 
responding to danger signals and any foreign microorganisms found in the host system.  
CNTs induced pulmonary exposure (in particular CB and Ti02) has shown to display 
inflammation in mice and rats causing the number of neutrophils in the BAL fluid to increase 
[36]. Cytokines which are formed by numerous cell types are produced to modify the cell 
function during acute inflammation. Although exposure to low doses of TiO2   does not cause an 
increase in inflammation, the particles are retained in the lung tissue where they cause an 
alteration to the gene expression of pro-inflammatory cytokines [37]. 
Pharmacokinetics 
An understanding of the pharmacokinetics (PK) of NPs is essential to examine their toxicity 
potential. PK gives quantitative information about the behaviour of NPs in the biological 
systems. 
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Absorption 
Upon injection, the  surfaces of NPs are readily covered by different blood plasma proteins 
forming the protein corona which has a significant role in determining what surfaces are 
offered to cells  which take up the NPs and activate signalling pathways. [3] The NPs for other 
routes of exposure, however, have to pass through other physiological barriers e.g. the skin or 
the lungs before gaining entry into the bloodstream. The different characteristics of NPs 
including size, shape and  surface charge are some of the factors that determine the interaction 
of NPS with the proteins. This protein absorption is highly responsible for determining the 
biodistribution of the NPs in the body e.g. the adsorption of fibrinogen, IgG, or complement 
factor is shown to support phagocytosis and hence the removal of NPs from the bloodstream. 
[3] 
Distribution 
NPs when absorbed can be distributed to many organs in the body. However, currently there 
only a few recent studies that examine the biodistribution of NPs in the body by quantitatively 
tracking the location of the NPs at different time points and different doses. [3] As stated 
earlier, the different characteristics of NPs such as the surface chemistry, shape, size, and 
aggregation state highly influence their biodistribution. Some studies with the single walled 
CNTs, that high percentage of NPs could accumulate in the liver depending on the surface 
changes. [3] Moreover, the NPs could be distributed to other organs including lymph nodes, 
spleen, or bone marrow which contain a significant number of macrophages.  
Metabolism 
There are very few reports regarding the metabolism of NPs. Out of all the different NPs, 
polymer-based NPs have been shown to to degrade in tissues.[3] Enzymatic metabolism in NPs 
such as gold and silver has always been considered improbable, however recent studies showed 
that some enzymes can actually degrade bio-persistent CNTs e.g neutrophil mycloperoxidase 
[3]. Metabolism of NPs in the liver usually occurs in phases I and II of the metabolic pathway. In 
phase I, formation of a new or altered functional group by the process of redox or polarity is 
seen. Phase II reactions involve conjugation of endogenous compounds to maximise water 
solubility and lower chemical reactivity. Phase II often occurs after the NPs have been rendered 
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more reactive by phase I metabolism. It is very important to understand the exact mechanisms 
of degradation of NPs.[3]                                                                                                                                                                                                                                                                                                              
Elimination 
Elimination has many channels by which it can occur. It can occur via, amongst other routes, 
seminal fluids,perspiration, mammary glands, saliva and exhaled breath. Urine via the kidneys 
and the feces via the biliary duct are the primary routes of NP elimination. Studies conducted 
on NPs showed that they are in fact not excreted and remain intact in vivo[3]  
A study by Choi et al [14], showed that NPs smaller than 5nm were excreted in urine (in mice) 
however their long term behaviour in vivo remains unclear . Inflammation in response to the 
nanostructures was however noted in the liver.[3] 
 
Chemical and Physical properties of nanoparticles affecting their  toxicity 
The physicochemical properties affecting the biological interaction of NPs should be evaluated 
in determining their level of toxicity.  
 
Particle size and surface area 
Particle size and surface area seem to be the most critical parameters affecting the toxicity of 
NPs because interaction of NPs with the biological molecules occurs at the surface. Decrease in 
the size of a particle leads to an exponential increase in surface area per mass[3], leaving a 
greater proportion of the particle available for interaction. This in turn increases the reactivity 
of the NPs towards itself and the surrounding molecules. Moreover, the dependence of the 
toxicity potential of NPs on their size could also be due to the size-related ability of NPs to 
readily enter the biological systems changing the structure of the proteins through NP-protein 
complex formation or enhanced protein degradation. 
Studies have also indicated [3] that the small size and the resulting large surface area also 
increases the formation of the reactive oxygen species(ROS). This results when the electron 
donor/acceptor sites of the NPs react with the molecular oxygen to form superoxide anions or 
hydrogen peroxide eventually oxidising other molecules, hence causing tissue injury.  
Lastly, NPs sized less than 50 nm are shown to be potentially toxic and disperse quickly into 
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almost all tissues, accumulating in blood, kidney hearts lung, liver, spleen, thymus, brain and 
even the reproductive organs whereas larger particles sized ~100-200 nm were found in the 
reticuloendothelial system (RES) tissues but comparative to smaller particles,  less dispersed in 
the other tissues.[3, 26, 27] 
Particle shape 
NPs exist in many different shapes such as fibres, platelets and tubes. In vivo, shape influences 
the membrane warping process during phagocytosis. [3] [42] In a study  [43] ,for example, it 
shows that the the phagocytosis process is faster in spherical NPs compared to fiber or rod 
shaped particles. In the CNTs which are long and fibre shaped it has been to shown to result in 
inefficient phagocytosis and harm to macrophages which causes the release of harmful oxygen 
radicals and hydrolytic enzymes extracellularly. For example, in a study [44], post intra-
abdominal instillation of long multiwalled carbon nanotubes(MWCNTs)  resulted in 
inflammation, whereas no inflammation and successful phagocytosis was observed and with 
the short MWCNTs. 
Medium containing NPs  
Proper suspension of NPs in the delivery medium is crucial for their biological distribution and 
activity. If agglomeration occurs, NPs may not be able to produce a stable suspension which is 
suited for the in vivo experiments. Conditions in the medium such as the pH or the ionic 
strength may influence the dispersion of NPs. In a study [45], NPs such as CB have shown to 
have a bigger size in Phosphate-buffered saline (PBS) than in water [45]. Moreover the toxicity 
of NPs is also dependent on the dispersion agents in the different media for example in a 
study,Sager et. al. [45] found out that by adding a dispersion agent in the PBS facilitated the 
dispersion of TiO2 and other carbon-based NPs but at the same time it increased the 
inflammatory response of the rats after they were instilled intratracheally. 
Surface Charge 
Surface charge influences the adsorption of ions and biomolecules that may affect the 
relationship between cellular or organism responses towards particles. It is also a key factor in 
bringing out the colloidal behaviour of the organism by changing the shape of NPs through 
agglomerate formation.  [3] It is believed that positively charged surfaces are far more toxic 
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than negatively charged ones. The plasma protein binding is also strongly determined by the 
surface charge which in turn affect the in vivo organ distribution and clearance of NPs from the 
circulation.[3] The surface charge also has an effect on the blood-brain barrier integrity and 
permeability. [46]NPs can further influence the the ability to permeate across the skin. In a 
study [46] it was revealed that negatively charged NPs ranging from 50-550nm in size 
permeated the skin. The 500nm NPs permeated because of the presence of a large number of 
charged groups [47] On the contrary, both the positively charged and neutral NPs did not 
permeate at all, regardless of the size. 
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Chapter 3: Methodology  
Literature review 
Research 
The data was gathered using a carefully selected and reliable search engine. The search engine 
that we designated for our literature research was PubMed. For more precise and relevant 
papers,we narrowed down our search to a few specific search terms i.e. graphene [Title], AND 
instillation[Title], OR graphene [Title] AND inhalation[Title].We also used nanotoxicology 
handbooks and various  internet sources for references. 
 
Experiment for determining protein concentrations 
Animals 
In this study, we used C57BL/6JBomTac female mice aged 6/7 weeks The mice were divided 
into groups, with 8 mice in each. Each group was provided with the same bedding, enrichment 
and ad libitum access to feed and water. The temperature and humidity conditions were kept 
constant at 21°C±2, 50%±5%. 
Particle exposure 
The mice were exposed to a high dose (162μg) of graphene materials (GO and rGO) suspended 
in Vehicle control (VC) (0.1% Tween 80 in water). The control groups were instilled with only 
the VC. Carbon black (CB)/Printex90 served as the positive control. BAL and tissue samples from 
lung and liver tissue were collected at time points 1, 3, 28 and 90 days. 
Procedure 
In this study, we used the PierceTM BCA Protein Assay which is a detergent-compatible 
formulation based on bicinchoninic acid (BCA) for colorimeter detection and quantitation of 
total protein. [6]The Microplate procedure was followed, which allows easy handling of the 
samples on a microplate, requiring only a small volume of 10-25 ml of a common protein 
sample, which is Bovine serum albumin (BSA) in this experiment. In order to determine the 
protein concentrations, a series of dilutions of known concentrations (standards) prepared 
from the protein, BSA, were assessed along with the unknown samples and thereafter the 
unknown protein concentrations were determined based on the resulting standard curve. 
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Before starting the microplate procedure, the standards and BCA Working Reagent were 
prepared. The preparation of the 9 standards and WR reagent is illustrated in Appendix A.  
After the preparation of BSA standards and the WR reagent, 25μl of each standard and 
unknown sample replicates were pipetted in microplate wells. To each well, 200μl of the 
already prepared WR was added and then the microplate was shaken on the plate shaker for 30 
seconds. After covering the plate, it was incubated at 37 ċ for 30-35 minutes. Lastly, the 
microplate was cooled to room temperature (RT), and the subsequent absorbance was 
measured at ~565 nm on a plate reader.  After the raw data was obtained, we made 
calculations of protein concentrations based on the following steps. 
 
1.    The mean of the 565 nm absorbance measurements of the blank standard replicates was 
subtracted from the 565 nm measurements of all the individual standards and the unknown 
sample replicates. (Corrected absorbance). 
2.      Next, the mean of the measured absorbance of all the unknown replicates and controls was 
taken. (Mean absorbance). 
3.       Standard curves for day 1, 3, 28 and 90, were plotted with the mean absorbance on the y-axis 
versus the concentration of each standard in μg/mL, on the x-axis. The standard curve for Day 1 
Day 3, 28 and 90 can be found in Figure 2 in the results section. 
4.      However since the best method for interpolating the unknown samples on the standard curve 
is by reference to a curvilinear regression, in this case a 2nd degree polynomial equation is fitted 
to each standard curve. 
5.      These equations were solved for x, where y is the mean absorbance and x represents the 
calculated protein concentrations in ug/mL.  
6.      Lastly, the average of the calculated protein concentrations for each particle was taken. Refer 
to the processed data tables in Appendix B. And, hence the results were plotted with protein 
concentrations in ug/ml on the y-axis and the name of particle on x-axis. Refer to figure 3 in the 
results section, below. 
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Chapter 4: Results 
Characterisation 
Table: 1 Characterisation of different types of graphene and other NPs. 
 
 
CB[8,10] GPs [8,10] CNTs10] Graphene nanopowder [5] GO[13] 
Experimental 
GO 
Experimental 
rGO 
Particle size(nm) 
- - - - 10-800 
 
260-295 
Projected diameter(µm) 
0.01 ± 0.01 5.64 ± 4.56 0.165 ± 0.00468 0.5 
0.308 ± 
0.0104 
5 1 
Layer number - 01-Oct - - - - - 
Surface area (m
2
/g) 
253.9 ~100 - 100 - 
 
422.69-499.85 
Density (g/cm
3
) 
~1.9 ~2 - - - 0.5 – 1.0 1.9 
EPR(Arbitrary units) 451.3 ± 52.2 867.3 ± 77.5 - - - - - 
Aerodynamic diameter (µm) <=2.5* 1.33 - 3.36 - - - - - 
Average aggregate 
thickness(nm) 
- 178 ± 57 - 
 
- - - 
Average flake thickness(nm) - - - 0.39-9.34 ~1 - - 
Length(µm) - - 36 - - - - 
% fibre greater than 15 µm 
- - 84.26 - - - - 
Purity (%) - - - 99.9 - - - 
C/O ratio based on EDS analysis 
(%)    
84.42 : 8.55 77-87: 13-22 49-56 : 41-50 - 
Source 
Evonik Degussa GmbH Cheaptubes.com 
University of 
Manchester [Dr. I. 
Kinloch] 
Graphene supermarket(Calverton,NY) - graphenea.com graphenea.com 
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Table 1 shows the characteristics of CB, GPs and CNTs are summarized in Table 1.This 
characterisation is done differently in different studies [5, 8, 10, 13], as evident from the 
missing data in the table.  
Graphene review 
Following pulmonary exposure, GPs deposit in the lungs and the pleural space, in particular [8]. 
Sanchez et al. revealed that there would be extensive deposition of the GP ranging from 0.001 
to 100 μm, all through the respiratory tract. [9] This deposition of the GP and their attempted 
uptake by the alveolar macrophages could result in frustrated phagocytosis, inflammation, 
failed clearance and translocation to the pleural space [8].Similarly, fiber shaped particles, if 
very thin and long can enter and reach the distal lungs where macrophages fail to engulf them 
leading to frustrated phagocytosis and inflammation. [8, 15] 
Schinwald et al in her study [8], investigated the health hazards of some types of commercially 
available GPs which consisted of several sheets of graphene (few-layer graphene) in the rat 
lungs from the aspect of aerodynamic deposition and cellular responses in the lungs. [4, 8] This 
study hence used models of both pharyngeal aspiration, direct intrapleural installation to 
examine the inflammatory potentials of GPs.  For comparison with GPs, CB was used. It was 
hypothesized that the shape of the NPs was the main factor driving their toxicity potential. 
Therefore, it was predicted that the respirable CB would be readily cleared by the alveolar 
macrophages whereas GPs, which are unable to be completely phagocytosed, after being 
translocated to the pleural space, would cause inflammation.The results showed  that the GPs 
which went up to 25μm in diameter, and a thickness of 0.1 μm, had an aerodynamic diameter 
of 3 μm and were in fact respirable and hence could penetrate beyond the ciliated airways after 
inhalation [4, 8, 9].However these large GPs were inflammogenic in both the lung and the 
pleural space in mice when delivered by either pharyngeal aspiration or direct intrapleural 
installation. To monitor the pulmonary inflammatory response, the GP was deposited in the 
lungs of mice by pharyngeal aspiration at a dose of 50μg. Results showed that at 1 day time-
point, the total number of cells mainly polymorphonuclear leukocytes(PMN) such as 
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neutrophils and eosinophils in the bronchoalveolar lavage(BAL), showed a significant increase. 
(Figure 2A) Similarly, the membrane leakage from cells determined by LDH assay, also showed a 
significant increase (Figure 2B). Lastly, on measuring the  concentrations of pro-inflammatory 
cytokines MCP-1, MIP-1α, MIP-1, and IL-1β, all had increased when compared to the VC and CB, 
but only MIP-2 seemed to have shown a significant increase in the concentration. (Figure 2C)  
The histological examination of lungs of mice exposed to GP revealed granulomatous lesions in 
the bronchiale lumen and near the alveolar region, whereas CB was comparable to VC. 
Figure 2: Inflammatory response in the lungs 1 day post exposure to CB and GP(A) Total cell number and total 
granulocyte number in the lavage fluid following exposure to CB and GP. (B) Measurement of the membrane 
leakage as LDH levels in the lavage fluid. (C) Concentration of the chemokines MCP-1 and MIP-1R as well as 
cytokines MIP-1 and IL-1β in BAL. [8] 
 
The experiment was continued to assess the one week exposure to GP/CB. It continued to show an 
increased inflammatory response to GP compared to CB and VC, but significantly  less in comparison to 
1 day post aspiration. (Figure 3) 
 
 
Figure 3: Inflammatory response in the lungs after 1 week exposure to CB and GP. A. Total cell number and total 
neutrophil number after pharyngeal aspiration of a single dose of 50 μg of CB and GP 1 week post treatment. 
n[8] 
 
To determine the pleural inflammatory response, mice were exposed to  CB and GP through 
intrapleural injection.The results were similar to the pulmonary inflammatory response. After 1 
day exposure, the total cell number, mainly due to neutrophils, had increased significantly 
compared to the VC. The cytokine MIP-1α protein level increased significantly. Moreover, the 
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CB was taken up completely by the pleural macrophages but the GP due to its shape and size, 
were unable to be phagocytosed completely and hence resulted in frustrated phagocytosis.  
Histological examination of the parietal pleura showed areas of histiocytic aggregates in mice 
exposed to GP. The area along the mesothelium was significantly increased compared to CB 
and VC at the 1 day time-point. The GP was largely associated with neutrophils along the 
parietal pleura. However, when continued to be exposed for 1 week, the inflammatory 
response resolved largely as denoted by the immense decrease in the total cell number 
compared to the day 1. 
Moreover, the clearance pathway of GP and CB was assessed from the pleural space to 
mediastinal cranial lymph nodes. CB was cleared from the pleural space after direct pleural 
injection via stomata to the cranial mediastinal lymph nodes after 1 day and 1 week.However 
for the GP, after 1 day, only a few particles could be found in the lymph nodes which indicates 
prolonged retention in the pleural space. Although after 1 week GP have been cleared from the 
pleural space but the amount of clearance appears to be much less compared to that of CB. 
 
Following this study [8], Schinwald et al. in her next study [10] focused on the medium term 
effects of GPs in the lung tissue of mice by investigating the pulmonary inflammation 6 weeks 
after pharyngeal aspiration of GPs. In order to measure the inflammatory response after 
aspiration exposure to GP and CB at 6 week time point, the lungs were lavaged and the total 
cell number was measured in the BAL fluid. Mice exposed to both GP or CB caused no 
significant increase in the total cell number but the total granulocyte number showed a 
significant increase in comparison to theVC. (Figure 4) However, this result does not represent a 
biological significance, as the number of granulocytes in the BAL fluid increased from 1% in the 
mice treated with VC to only 3.7% in the mice treated with GP.  
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Figure 4:Response to GP in the lungs at 6 weeks post aspiration. C57BL/6 mice were exposed to VC, CB and GP by 
pharyngeal aspiration. At 6 weeks the lungs were lavaged and total cell number and granulocyte (neutrophils, 
eosinophils, basophils) number were measured.[10] 
A more useful comparison of the level of inflammation after 24h, 1-week and 6-week are 
shown in Figure 5. This figure exhibits the decrease in the inflammation as a measure of total 
granulocyte number in the lung lavage fluid after exposure to GP and CB. Histopathological 
examination at 6 week time point revealed no granuloma formations or infiltration of 
neutrophils in the exposed mice lungs, which is indicative of low or no inflammogencity. The 
assessment of the collagen deposition which is indicative of lung fibrosis also showed no 
significant increase.The inflammatory response results were also compared to the CNTs. [10,12] 
The CNTs showed significant inflammation at 1 day, 1 week but a decrease in inflammation at 6 
weeks which was comparable to the VC. [12] CNTs further showed significant interstitial 
thickening and remodelling of the alveolar spaces, collagen deposition and lymphocyte 
infiltrates at a 6 week time point. [12] In Figure 8, after exposure to GP the total number of 
granulocytes decreased from 1 day to 6 weeks. CNTs, on the other hand, showed significant 
increase in inflammation at 1 day and 1 week which after 6 weeks then decreased to a level 
equivalent to the VC. 
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Figure 5: Time dependent inflammatory response in the lungs.[10] The figure (A) shows the number of total cells 
and (B) shows the total granulocyte number 1 day, 1 week and 6 week post aspiration exposure to CB, GP and CNT. 
Data for 1 day and 1 week time-point was obtained from Schinwald et al [8]. CNT data was obtained from Murphy 
et al. [12] 
 
In order to determine the pleural response to pulmonary exposure , the tissue and alveolar 
macrophages lying just under the visceral pleura were examined. The results showed no 
accumulations of GP. At all time-points of 1 day, 1 week and 6 week, no significant influx of 
neutrophils was measured compared to the VC. This translocation of GP was compared to the 
CNTs at 6 week time point [12], which showed translocation to the pleural space as indicated by 
the increase in the total cell number and total granulocyte number and accumulation of 
neutrophils on the mesothelium surface of parietal pleura. [12] 
 
Overall, the results in this study [10] showed minimal inflammation in mouse lungs after 6 
weeks, compared to 1 day and 1 week studies, [10, 12], however significant amounts of GPs 
were found deposited in the lungs with no degradation of GPs in the lung tissue. The result 
contradicted the hypothesis in this study [10], which expected an extended inflammatory 
response with the GP, just as with the CNTs [8],due to their extended lateral dimensions, 
leading  to frustrated phagocytosis at short time points and possible clearance from the lungs. 
[8] 
Moreover, the the study by Li et. al. [13], was used to investigate the biodistribution and 
pulmonary toxicity of GO in mice for up to 3 months. The results showed that GO primarily 
remains in the lungs after intratracheal instillation which is indicated by the SPECT imaging. The 
long term effects of the GO in the lungs were observed by looking at the morphological changes 
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of excised lungs. The lungs of the mice that were exposed to the GO displayed a black 
discolouration which indicated GO deposition in lung tissue(Figure 6) [13]. The discolouration 
was seen to have significantly reduced as from 24 hours to 3 month exposure. This observation 
seems to support the notion that GO is slowly washed out from the system with time. 
 
Figure 6: Morphological observation of the lungs from mice instilled with Milli-Q water or 10mg/kg GO. The dorsal 
view shows the distribution of GO.( the black region) [13] 
 
On the other hand,a histopathological assessment was conducted on the lungs and the results 
seem to show an obvious accumulation of alveolar macrophages in the bronchial lumen at 3 
months. This suggests that GO is taken up and cleared by alveolar macrophages and the 
macrophages are then eliminated through sputum from the body through mucociliary 
clearance or by other mechanisms[13,31,32]. Both the black discolouration on the lung surface 
after 3 months(Figure 6)  and the histopathological observation point towards incomplete 
clearance of GO. [13] 
Furthermore, the histopathological analysis of the lung tissue done after 0h, 24h, 48h, 72h and 
1 week showed that soon after intratracheal instillation of 10mg/kg of GO, the GO had primarily 
adhered to the inner surfaces of the bronchial and alveolar walls. A good dispersion pattern 
was observed with no blockage of bronchial lumina and alveolar spaces due to the formation of 
large aggregates. However, the GO consequently began to aggregate and along with this 
aggregation came with obvious inflammation to the pulmonary system.Because of this 
inflammatory response, the BAL fluid biomedical index which is used to measure cell injury was 
implemented. The index includes a measure of LDH(lactate dehydrogenase) activity, alkaline 
phosphatase (ALP) activity and total protein concentration. The results showed an increase in 
both LDH and ALP activities, the latter is a typical sign of  type II lung epithelial cell toxicity. 
(Figure 7a,7b) There was also an increase in  total protein concentration in the BAL fluid which 
implied the enhanced permeability of vascular proteins into the alveolar regions, which could 
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be due to the breakdown of the integrity of the alveolar-capillary barrier (Figure 7c).[13]The 
cells that were found from the BAL fluid were mainly neutrophils. (Figure 7e)
 
Figure 7: NGO causes dosage-dependent inflammatory response (a–e) BAL fluid LDH (a), ALP (b)and total protein (c) 
assays were performed to determine the level of cell injury. The lung wet/dry weight ratio (d) was used to evaluate 
the severity of lung edema. BAL fluid differential cell counting (e)was used to evaluate the number and types of 
migrated cells.[13]  
 
Overall, an excessive inflammatory response was noted in both  pulmonary and 
extrapulmonary stimuli  in the GO. [13]. 
Next, the time dependent pulmonary responses induced by GO were assessed. The results 
showed that GO induced early severe cell damage as both the ALP and LDH activities were 
elevated at 24 hours which then decreased after.(Figure 8a-b) Looking at the peaks of the BAL 
fluid total protein, lung wet/dry weight ratio and BAL fluid differential cell counts graphs, they 
all reach a peak value at 48 hours suggesting that this was the time point at which the most 
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severe cell disruption i.e lung edema,alveolar-capillary interface and neutrophil infiltration 
occurred. (Figure:8c-e).  
 
 
Figure 8: Inflammatory response at different time points[13] (a–e) BAL fluid LDH (a), ALP (b) and total protein (c) 
were performed to determine the level of cell injury. The lung wet/dry weight ratio (d) was used to evaluate the 
severity of lung edema. BAL fluid differential cell counting (e) was used to evaluate the number and types of 
migrated cells. 
 
 
Overall, the results furthermore show that GO-induced inflammatory response show greatest 
severity at 48 hours after instillation, whereupon it then starts to decrease beyond that point. 
After a week, the organisation of lung tissue and fibroproliferation point towards possible lung 
fibrosis. Histopathological analysis performed at the 1 month and 3 month post exposure point 
clearly towards an accumulation of alveolar macrophages loaded with GO in the lung, with 
obvious collagen deposition and neutrophils surrounding these alveolar macrophages. 
Moreover, the bronchial lumina after 3 months exposure, had become narrowed in size 
showing further aggravation of the fibrotic response. These results indicate that GO induced 
diffuse pulmonary fibrosis over a longer term.  
Furthermore, Shin et. al in his short term inhalation study [5] with male rats, further assessed 
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the toxic effects of GPs. The rats were exposed 6 hours per day to GPs for 5 days, followed by 
recovery for 1, 3,7 or 28 days. Three groups of rats were compared with 20 rats  per group: 
control(ambient air), low concentration(0.68 ± 0.14 mg/m3 graphene), and high 
concentration(3.86 ± 0.94 mg/m3 graphene). When it came to observation of the rats including 
their food consumption and effect on body and organ weights, there were no significant gross 
effects noted during the exposure and recovery periods. A substantial amount of body weight 
loss was noted for the low-dose and high-dose group  after the 5-day exposure,3-day recovery 
and during week 2. Also, after doing an examination of the rat organs, no significant clinical 
signs or organ weight losses were recorded at any of the examination points.  
 
Although, only a small number of markers out of the 20 hematology parameters used in this 
study showed significant changes, the hematological tests of the rat blood showed significant 
changes in the number of neutrophils, lymphocytes and monocytes for the high dose group 
compared to the control after 5 day exposure to GP and 1-day recovery period. However, after 
the 3-day recovery period, the number of white blood cells and lymphocytes decreased 
significantly, in the high dose group. 
Furthermore, when the LDH activity in the BAL fluid was measured, in order to determine the 
the lung cell damage no significant changes were found. The results from counting the BAL cells 
(i.e. total cells, macrophages, neutrophils and lymphocytes) showed no significant changes 
following the GP exposure at all the time points tested. 
The histopathological examination of the rat lungs revealed no significant changes for the low 
dose group and only  a slight thickening of the alveolar wall in 3 of the 5 rats in the high-dose 
group after 5 day exposure and 1-day recovery- Moreover, the alveolar macrophages were also 
examined , which after 3-day recovery revealed thickening of the alveolar wall in 3 of the 5 rats 
but was reduced to just one of the rats after 7 days of recovery. Lastly, no significant changes 
were noted in either groups after 28 days of recovery. GPs was visualised in the alveolar 
macrophages for both the low and high dose groups after the 5 days of GP exposure and 1,7 
and 28 days of recovery.[5]  
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Experimental data on protein concentrations 
The standard curves obtained for the same standards used for 1, 3, 28 and 90 day post 
exposure are plotted in below in Figure 9. 
 
Figure 9: Standard curve Day 1, 3, 28 and 90. These Standard curves were plotted with the mean absorbance on the 
y-axis versus the concentration of each standard in μg/mL, on the x-axis. 
 The standard curves were the same for Day 1 and Day 3, but the standard curve obtained for 
Day 28 and 90 shows completely different sets of data points compared to the other two 
standard curves. The time taken during the preparation of standards, until they were used to 
measure the absorbance seems to be the factor causing these variations. The samples for day 
28 and 90 were measured last therefore due to this prolonged waiting time , the water in the 
standards might have dried up, leaving the BSA standards more concentrated.  
The average of the calculated protein concentrations in the BAL fluid for each particle was 
taken and  plotted.(Figure 10) 
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Figure 10: Graph for protein concentrations in the BAL for Day 1, 3 28 and 90. 
 
The protein concentrations in mice exposed to GO increased from Day 1 to Day 3 but decreased 
drastically until Day 90 compared to the VC and CB(Printex-90), for which the protein 
concentrations only decreased between Day 1 and 3 and 28, but stayed constant afterwards 
until day 90. For rGO on the other hand, the protein concentration seems to decrease from Day 
1 to Day 90 but this result seems very insignificant compared to the VC.  
 
Inflammation/Number of neutrophils: 
 
The unpublished data on inflammation was provided by our supervisor which were then plotted 
(Figure 11) to see the extent of inflammation as a measure of the neutrophil number in the 
BAL. 
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Figure 11: Graph for number of neutrophils for Day 1, 3 28 and 90. 
 
The number of neutrophils increases from Day 1 to Day 3 from exposure to GO, but drastically 
drops to very low values for Day 28 and Day 90 subsequently, as compared to the VC and CB.  
From exposure to CB, the neutrophil number decreased only slightly between day 1 and 3, then 
decreased to a very low value until Day 28 which stayed constant until day 90.  Post exposure to 
rGO showed very low inflammation, with a slight decrease in the neutrophil number between 
Day 1 and 3, and constant number until day 90. 
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Chapter 5-Discussion and Analysis 
Discussion  
Graphene which have only recently been identified has drawn attention of many scientists due 
to its exclusive properties particularly the platelet-like shape it can exist in which seems to be 
central to their toxicity potential.[8] GPs exhibit specific material properties that could be 
important for biological interactions including the high surface area per mass unit which is 
much greater than that of other similar carbon materials such as graphite and CNTs [11], the 
surface chemistry and lateral dimensions. However, thus far there is very little information 
existing on the inhalation toxicity of GPs. 
The aim of this study was to investigate the the potential toxicity of graphene materials with 
particular focus on pulmonary exposure in the working environments, using in vivo studies. This 
study combines the currently existing literature on the short, medium and long term pulmonary 
inflammogenicity of the the recently discovered graphene materials with different 
characterizations (Table 1) and their comparison to other widely explored NPs such as CNTs and 
CB. Moreover, experimental data from an ongoing study assessing short and long term 
inflammation and total protein concentration in BAL fluid of GO and rGO was also included. 
The literature findings on the time related pulmonary inflammation, from the three studies on 
instillation[8,10,13] were to some extent consistent with our experimental data regarding the 
toxic potential of GPs particularly pulmonary inflammation measured in terms of the protein 
concentrations and macrophage cell count. Schinwald et. al in her studies [8,10] made a 
comparison of the level of pulmonary inflammation after 1 day, 1-week and 6-week post 
exposure to GP and CB(Figure 5). The results revealed a decrease in the inflammation from day 
1 to 6 weeks in the lung lavage fluid after exposure to GP and CB. GP results are consistent with 
our experimental data on the inflammation from post exposure to rGO which showed a 
decrease in the inflammation throughout from day 1 to day 90. (Figure 11) The results from 
Schinwald papers [8], [10] also showed an increase in the concentration of proinflammatory 
cytokines from exposure to GPs after 1 day compared to the VC and CB, which fits with our 
experimental data on the protein concentrations from exposure to GO and rGO which show an 
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increase in protein concentrations at day 1 compared to the VC and CB.(Figure 10) Moreover, 
the results from Li et. al. study [13] which showed an increase in the  BAL fluid total protein and 
BAL fluid differential cell counts from exposure to GO, until  Day 2 and then decreased until 
after 1 week (Figure 8c-e) further supports our experimental data on both inflammation and 
protein concentrations in the BAL fluid from exposure to GO. (Figure 10, 11) The GO-induced 
inflammatory response show greatest severity at 48 hours after instillation, whereupon it then 
starts to decrease beyond that point both in our experimental results (Figure 10,11) and by Li 
et. al.(Figure 8c-e) Schinwald also compared the inflammatory response results to the CNTs. 
[10,12] The CNTs showed significant inflammation at 1 day, 1 week but a decrease in 
inflammation at 6 weeks compared to the VC. [12] This can be compared to our results from 
the exposure to GO which show an increase in inflammation at day 1 to upto 3 days and a 
drastic decrease from Day 3 to until Day 90.(Figure 11) The study by Shin. et al. [5] following 
inhalation as the exposure technique however did not show any significant change in 
inflammation or protein concentrations in the BAL fluid.  
Moreover, the findings from literature studies showed that there would be extensive 
deposition of GPs ranging from 0.001 to 100 μm, all through the respiratory tract [9] [13] and 
this deposition of the GP and their attempted uptake by the alveolar macrophages could result 
in frustrated phagocytosis, inflammation, failed clearance and translocation to the pleural space 
[8].Similarly, risks will be observed for fiber shaped particles such as CNTs. Results showed that 
the GPs up to 25μm in diameter were respirable after inhalation [4, 8, 9]but caused 
inflammation in both the lungs and the pleural space in mice. CB was taken up completely by 
the pleural macrophages but the GP due to its shape and size, were unable to be phagocytosed 
completely and hence resulted in frustrated phagocytosis. We would expect the same from our 
data since the GO and rGO used had a diameter of 5μm and 1μm,respectively and therefore 
could be causing inflammation and their attempted uptake by the alveolar macrophages could 
result in frustrated phagocytosis. The clearance pathway of GP and CB was also assessed from 
the pleural space to mediastinal cranial lymph nodes. CB was cleared from the pleural space 
after 1 day and 1 week. However the GP, after 1 day, showed prolonged retention in the pleural 
space and after 1 week GP were cleared from the pleural space but the amount of clearance 
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was much less compared to that of CB. [8] After 6 weeks significant amounts of GPs were found 
deposited in the lungs with no degradation of GPs in the lung tissue. An extended inflammatory 
response was expected with the GPs, just as with the CNTs [8, 10]and possible clearance from 
the lungs [8] but the results showed minimal inflammation. [10]  Similarly the lungs of the mice 
that were exposed to the GO (10mg/kg) displayed a black discolouration(Figure 6) [13], this 
dose related pulmonary response can be compared our experimental data, where we exposed 
the mice to 8.4mg/kg GO so we would also expect a black discolouration in the lungs of mice 
indicating GO deposition. The discolouration was seen to have significantly reduced as from 24 
hours to 3 month exposure which again coincides with our experimental data where the 
inflammation from post exposure to GO increased between day 1 and day 3, then decreased 
until day 90 supporting the notion that GO was cleared from the lungs. 
One drawback of the the experimental data we used in this study is that statistical analysis was 
not included.Furthermore, the standard curves we got from the 9 different BSA standards, were 
same for Day 1 and 3 but by the time we assayed the standards and the unknown samples from 
day 28 and 90, the water in the standard solutions might have dried up leaving the standards 
much concentrated, therefore the standard curve for day 28 and 90 (Figure 9), gave completely 
different data sets with, much higher mean absorbance values. 
In this review, when  the characteristics of different graphene materials used in different 
studies [5,8,10,13], were studied and compiled in Table 1, it was realized that there was a lot of 
essential data missing such as the surface area of the graphene material used.In our study, the 
characterization of GO and rGO was only what we had received from the manufacturer. This 
shows that the researchers do not agree on a common characterization of graphene derivatives 
and other NPs such as CB and CNTs, which could be one of the reasons why so less knowledge 
about the toxicity potential of graphene and other NPs currently exists.  
Therefore, in future studies, it is possible that researchers should agree on a common 
characterization of graphene and other NPs such as CNTs and CB. The papers should indicate 
the characteristics that might be most influential on the toxicity potential of the NP and the 
characterization should not only be based on what was received from the manufacturer but a 
more detailed analysis should be done with different techniques. Moreover, in the background 
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it was discussed how the different physicochemical properties such as the particle size, shape 
or surface area affect the potential toxicity of NPs. It could be a possibility, in future studies , to 
further investigate using experimental methods how these properties play a role in determining 
the GPs toxicity following pulmonary inflammation. 
Moreover, comparison of the two exposure techniques shows that it is safe to say that the 
inhalation method provides the most realistic simulation to real life exposure. However, it is 
more expensive in terms of the required machinery to conduct an effective experiment and 
also more time consuming than instillation. For studies using instillation [8,10,13] the GO was 
seen to stay longer in the lung tissue than in the inhalation study and hence expressing a longer 
inflammation period (that is, for as long as the experiment was conducted i.e 90 days whereas 
it cleared up in the inhalation studies after only 28 days).[5]. Also, for the intratracheally 
instilled samples,more adverse effects were observed than in the inhalation ones. No major 
clinical observations were noted in the 5-day inhalation study [5] and this could be on the 
account that it just was not conducted for enough time. The fact that instillation is a bolus 
exposure method means that it runs the big risk of causing severe damage to the subject if 
done the wrong way. Administration of the GP had to be precise otherwise the mice/rats could 
have died from either speed shock or even worse venous haemorrhage(among other 
effects).[41]  
 Another reason why we got better results from the studies using instillation could be that the 
graphene samples used in the different experiments were all different and not produced from 
the same company. Perhaps the graphene used in the instillation experiments had a higher 
affinity to the mice/rats used and hence showing more results.  
As we have already established earlier, inhalation experiments are more time consuming and 
because of that it is possible that that is the reason we were not able to get substantial results 
in the designated time the experiment was conducted in. This is because GP,like carcinogens 
and other substances of a similar nature have long term effects and start to express 
pathogenesis after a long time(12-20 years before actual disease kicks in and potentially up to 
40 years).[38,39,40]  
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Conclusion 
This study highlights the toxicity potential of the newly discovered GPs which now have 
extensive industrial applications due to the intrinsic properties they exhibit. [8,30] The 
literature findings and our experimental results suggest that from exposure to rGO there 
occurred increased inflammation 1 day post exposure, compared to VC and CB. The 
inflammation decreased afterwards up until 3 months(Figure 5,11). Whereas, from exposure to 
GO, there was an increase in inflammation, until  Day 2 and which then decreased until after 1 
week (Figure 8c-e) and 3 months (Figure 11). Moreover, the CNTs also showed significant 
inflammation at 1 day, 1 week but a decrease in inflammation at 6 weeks compared to the VC. 
[12] However, due to the lack of available knowledge, we suggest that more research needs to 
be conducted to further investigate the medium term and long term effects of exposure to 
graphene materials. 
Further, the results from literature studies showed that GPs ranging from 0.001 to 100 μm, 
were found to be extensively deposited all through the respiratory tract [9,13] GPs which went 
up to 25μm in diameter caused inflammation in both the lungs and the pleural space. They 
could not be engulfed completely by the macrophages due to their platelet like shape and large 
size, causing frustrated phagocytosis. We expect the same from our data where we use GO and 
rGO sized 1μm and 5μm. Therefore, we suggest that potential risks from exposure to GPs could 
be limited by manufacturing GPs small enough to be phagocytosed completely by the 
macrophages.  
Based on the results we collected from the two exposure methods, it would seem that 
instillation was the better method to use when inspecting the effects of GPs following 
pulmonary exposure. Not only did did it provide us with the most significant results, but it is 
also very practical, cheap and easy to monitor. The inhalation study did not provide us with 
sufficient data but as we have established already inhalation simulates real life exposure and 
therefore in the future more focus should be given to  inhalation studies to investigate medium 
term and long term effects from exposure to GPs. 
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Appendices 
Appendix A: Preparation of BSA standards 
Table 1: Preparation of diluted BSA standards [6] 
Vial Standard label in 
raw and processed 
data tables 
Volume of Diluent 
(μL) 
Volume and Source 
of BSA (μL) 
Final BSA 
Concentration 
(μg/mL) 
A 8 0 300 of Stock 2000 
B 7 125 375 of Stock 1500 
C 6 325 325 of Stock 1000 
D 5 175 175 of vial B dilution 750 
E 4 325 325 of vial C dilution 500 
F 3 325 325 of vial E dilution 250 
G 2 325 325 of vial F dilution 125 
H 1 400 100 of vial G dilution 25 
I 9/Blank 400 0 0 = Blank 
 
 
For the preparation of WR reagent, first we calculated the total volume required using the 
following formula [6]: 
Total volume WR required = (Number of standards + Number of unknowns) × (Number of 
replicates) × (Volume of WR per sample) 
Since, for this experiment, we had 9 standards, 208 unknowns, 2 replicates and 0.2 ml per 
sample. 
Total WR required = (9 × 208) × 2 × 0.2ml = 86.8 ml ~ 90 ml 
And thereafter WR was prepared by mixing BCA Reagent A and Reagent B in a 50:1 ratio. 
Volume of Reagent A used = 88.2 ml 
Volume of Reagent B used = 1.8 ml 
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Appendix B: Processed experimental data 
Table 2: Summary table for Protein concentrations 
 Average. Protein 
conc.(ug/ml) 
Control Day 1 179.1134211 
GO Day 1 585.0425108 
rGO Day 1 187.2644223 
Printex90 Day 1 279.4406301 
Control Day 3 149.18 
GO Day 3 1416.02 
rGO Day 3 143.3930594 
Printex90 Day 3 258.284724 
Control Day 28 29.66271897 
rGO Day 28 25.00141396 
Printex90 Day 28 58.36217054 
Control Day 90 11.6812281 
rGO Day 90 25.73530033 
Printex90 Day 90 43.01765284 
 
Table 3: Summary table for Number of neutrophils 
Particle 
Average number of 
neutrophils 
Control Day 1 8.52E+03 
GO Day 1 1.21E+05 
rGO Day 1 4.33E+04 
Printex 90 Day 1 1.06E+05 
Control Day 3 5.08E+02 
GO Day 3 5.74E+05 
rGO Day 3 5.26E+03 
Printex 90 Day 3 1.01E+05 
Control Day 28 7.18E+02 
GO Day 28 7.05E+02 
rGO Day 28 6.46E+03 
Printex 90 Day 28 2.04E+04 
Control Day 90 2.68E+02 
GO Day 90 2.99E+03 
rGO Day 90 7.01E+03 
Printex 90 Day 90 1.92E+04 
 
 
